Biologics (Cell Therapies. gene Therapy) Flashcards

1
Q

What are biological therapies?

A
  • Peptides / recombinant therapies
  • Gene therapy
  • Cell therapy
  • Monoclonal antibodies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is gene therapy?

A

The transfer of genetic sequences that alter the DNA of a cell for therapeutic purposes

Delivery of genetic sequences that alter the instruction set of a cell for therapeutic purposes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the genetic sequences used in gene therapy?

A
  • Synthetic copies of genes that encode a specific protein

- Short genetic sequences that knockdown the expression of a specific gene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Whats a variation of gene therapy?

A

Somatic cell gene therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is somatic cell gene therapy?

A

Therapy is restricted to the patient and genetic material is not passed onto their offspring

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What would the ideal gene therapy approach be?

A
  • Be highly specific leading to reduced side effects

- Produce a long term therapeutic effect following a single application

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What would ideal gene therapy involve?

A

Aim: To deliver the therapeutic gene to the organ/cell of interest

Problem: Mammalian cells are very efficient at getting rid of foreign DNA

Solution: Therapeutic genes are delivered using gene delivery vehicles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the gene delivery vehicles?

A
  • Non-viral vectors : PLasmids, siRNA, lipsomes

- Viral vectors: Genetically modified viruses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How are viruses used as vectors?

A
  • Exploit the natural life cycle of a virus
  • Viruses bind to membrane bound receptors and have evolved efficient ways to gain access to the nuclear transcriptional machinery
  • Remove the virus replication genetic material, left with shell, replace with therapeutic transgene
  • most viral vectors nowadays are safe
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How do viral vectors work?

A

-Penetrate a cell, use its nuclear machinery and produce therapeutic proteins(no viral genes replicated)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Whats the difference between ex-vivo and in-vivo gene therapy?

A

Ex-vivo = Genetic modification performed on cells in a dish before transplantation in the patient

In-vivo = Genetic modification performed directly in the patient

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What does the success of gene therapy depend on?

A

Success of gene therapy depends on the efficiency of gene transfer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Whats the example for gene therapy?

A

Parkinsons disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What does PD primarily affect?

A

Loss of dopamine cells in SNpc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Whats the stage one strategy for pd?

A

Dopamine replacement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How does dopamine replacement work?

A

Aim: Increase dopamine synthesis locally in the striatum

How: Transfer genes involved in dopamine synthesis to the neurons in the striatum

Problems: Does not prevent disease progression; amount of dopamine produced is hard to control

17
Q

What is the second strategy for PD?

A

Neuroprotection

18
Q

How does neuroprotection work for PD?

A

Aim: Boost production of growth factors involved that promote dopamine cell survival and axonal regeneration i.e glial cell derived neutrotrophic factor (GDNF) and Neurturin

How: Introduce GDNF or Neurturin genes into the brain

19
Q

What is cell therapies?

A

Therapies involving the injection of living cells into a patient i.e bone marrow transplants

20
Q

What are the types of cell therapies?

A

Autologous : Cells removed from patient, modified and returned

Allogenic : Cell donor is different person

Syngeneic : Cell donor is genetically identicle (twins)

21
Q

What sorts of cells are used in cell therapy?

A

Cells can vary:

  • Stem cells (cultivated into other cells)
    • Blastocyte
    • heDSC
    • adult CNS
    • Fetal CNS
    • Bone marrow
    • Fibroblast
22
Q

How do cell therapies work?

A
  • Replace damaged tissue

- Release therapeutic proteins

23
Q

How does the replaced damaged tissues cell therapy work?

A

-Stem cells or progenitor cells are differentiated into a specific cell type in the lab. Cells are grafted into site of injury

24
Q

How does the release therapeutic proteins cell therapy work?

A
  • Transport cells that have the capacity to release soluble factors i.e cytokines, chemokines, growth factors
    e. g insulin
25
Q

What are antibodies?

A

Antibodies (immunoglobulins) are proteins that fucntion to identify and neutralize pathogens such as viruses or bacteria

Antibodies recognize and bind to specific antigens

26
Q

What does monoclonal antibodies for human therapies involve?

A
  • Specific for one antigen
  • Typically iGg subtype
  • Have been humanized or are chimeric antibodies
  • Currently, commerical antibody therapies are mainly for cancer and immune disorders
27
Q

What are the modes of action for many cancer immunotherapies?

A
  • Antibody binds to a soluble ligand involved in cancer growth
  • Antibody binds to a cell surface receptor on a tumor cell
  • Antibody binds to tumor antigen induces human immune effector responses
28
Q

What happens when Antibody binds to a soluble ligand involved in cancer growth?

A
  • Interferes with its activity and interaction with binding partners
    i. e avastin (Bevacizumab) used for treating colorectal cancer, binds to the ligand VEGF-A
29
Q

What happens when Antibody binds to a cell surface receptor on a tumor cell?

A
  • Blocks its interaction with a ligand
  • Interferes with signalling pathways important in maintaining tumor growth
  • triggers receptor internalisation or apoptosis of tumor cells

i.e trastuzumab (herceptin) used for treating metastatic breast cancer targets HER2 receptor